Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | GLS | O94925 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.47 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25314409 | 0.90 | NR1H2 (0.48) | HPGDKDM4EPKMGLSRECQL | |
| SCHEMBL25311767 | 0.90 | NR1H2 (0.48) | HPGDKDM4EPKMGLSRECQL | |
| SCHEMBL28062966 | 0.87 | HPGD (0.50) | HPGDKDM4EPKMGLSRECQL | |
| SCHEMBL6608848 | 0.87 | HPGD (0.53) | HPGDKDM4EPKMGLSRECQL | |
| SCHEMBL584378 | 0.87 | KDM4E (0.54) | HPGDKDM4EPKMGLSRECQL | |
| SCHEMBL3782148 | 0.85 | HPGD (0.55) | HPGDKDM4EPKMGLSRECQL | |
| SCHEMBL1489755 | 0.85 | HPGD (0.51) | HPGDKDM4EPKMGLSRECQL | |
| SCHEMBL14602992 | 0.85 | HPGD (0.51) | HPGDKDM4EPKMGLSRECQL | |
| SCHEMBL3220450 | 0.85 | HPGD (0.51) | HPGDKDM4EPKMGLSRECQL | |
| SCHEMBL3220460 | 0.85 | HPGD (0.51) | HPGDKDM4EPKMGLSRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114080385-B | Herbicidal compounds | 先正达农作物保护股份公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-114080384-B | Herbicidal cyclohexanedione derivatives | 先正达农作物保护股份公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-113423693-B | Herbicidal compounds | 先正达农作物保护股份公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-111868033-B | Herbicidal 3-azaspiro [5.5] undecane-8, 10-dione compounds | 先正达参股股份有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-113423692-B | Substituted azaspiro compounds as herbicides | 先正达农作物保护股份公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-113412256-B | Herbicidal compounds | 先正达农作物保护股份公司 | 2024-01-19 | — | — | CN | disclosed |
| CN-111886229-B | Herbicidal compounds | 先正达参股股份有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-111868034-B | Spirocyclic cyclohexanedione derivatives as herbicides | 先正达参股股份有限公司 | 2023-12-01 | — | — | CN | disclosed |
| US-RE49686-E1 | Nitrogen-containing heterocyclic compound and use of same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-10-10 | — | — | US | disclosed |
| US-RE49686-E1 | Nitrogen-containing heterocyclic compound and use of same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-10-10 | — | — | US | disclosed |
| WO-2003040147-A1 | AZABICYCLIC-SUBSTITUTED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE__________________________________________________________________________________________________________________________ | PHARMACIA & UPJOHN COMPANY (US) | 2003-05-15 | — | — | WO | disclosed |
| WO-2003037896-A1 | N-AZABICYCLO-SUBSTITUTED HETERO-BICYCLIC CARBOXAMIDES AS NACHR AGONISTS | PHARMACIA & UPJOHN COMPANY (US) | 2003-05-08 | — | — | WO | disclosed |
| WO-2003029252-A1 | AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE | PHARMACIA & UPJOHN COMPANY (US) | 2003-04-10 | — | — | WO | disclosed |
| EP-0946165-B1 | INTEGRIN ANTAGONISTS | MERCK & CO INC (US) | 2003-04-09 | — | — | EP | disclosed |
| WO-2002085901-A1 | SUBSTITUTED AZABICYCLIC MOIETIES FOR THE TREATMENT OF DISEASE (NICOTINIC ACETHYLCHOLINE RECEPTOR AGONISTS) | PHARMACIA & UPJOHN COMPANY (US) | 2002-10-31 | — | — | WO | disclosed |
| US-6358970-B1 | FOR THERAPY AND PROPHYLAXIS OF OSTEOPOROSIS, AND INHIBITING VASCULAR RESTENOSIS, DIABETIC RETINOPATHY, MACULAR DEGENERATION, ANGIOGENESIS, ATHEROSCLEROSIS, INFLAMMATION, ARTHRITIS, VIRAL DISEASE, CANCER, AND METASTATIC TUMOR GROWTH | MERCK & CO., INC. | 2002-03-19 | — | — | US | disclosed |
| EP-0946165-A4 | INTEGRIN ANTAGONISTS | MERCK & CO INC (US) | 2001-04-11 | — | — | EP | disclosed |
| EP-0946165-A1 | INTEGRIN ANTAGONISTS | Merck & Co., Inc. (US) | 1999-10-06 | — | — | EP | disclosed |
| US-5952341-A | VITRONECTIN RECEPTOR ANTAGONISTS FOR INHIBITING BONE RESORPTION, TREATING AND PREVENTING OSTEOPOROSIS, AND INHIBITING RESTENOSIS, DIABETIC RETINOPATHY, TUMOR, MACULAR DEGENERATION, ANGIOGENESIS, ATHEROSCLEROSIS, INFLAMMATION | MERCK & CO., INC. (US) | 1999-09-14 | — | — | US | disclosed |
| WO-1998018460-A1 | INTEGRIN ANTAGONISTS | MERCK & CO., INC. (US) | 1998-05-07 | — | — | WO | disclosed |